首页> 外文期刊>Gynecological Surgery >Laparoscopic surgical staging for uterine malignancies using harmonic shears (UltraCision) in comparison to electrosurgery: operative technique, feasibility and complications
【24h】

Laparoscopic surgical staging for uterine malignancies using harmonic shears (UltraCision) in comparison to electrosurgery: operative technique, feasibility and complications

机译:与电外科手术相比,使用谐波切开术(UltraCision)进行腹腔镜子宫分期术对子宫恶性肿瘤的手术技术,可行性和并发症

获取原文
获取原文并翻译 | 示例
           

摘要

This retrospective study assesses and compares perioperative parameters in two groups of patients treated by different operative techniques of laparoscopic surgical staging (LASS) for uterine cancer. Between April 1996 and May 2005, 119 consecutively selected women with cervical cancer (n=30) or clinical stage I endometrial cancer (n=89) underwent laparoscopic assisted vaginal hysterectomy (LAVH), total laparoscopic hysterectomy (TLH) or radical laparoscopic assisted vaginal hysterectomy (RALVH) plus bilateral salpingo-oophorectomy (BSO) and/or lymph node dissection (LND) during a primary surgical procedure using an electrosurgery (ELC, n=37) or ultrasonic (US, n=82) operative technique (harmonic shears, UltraCision). The UltraCision was used as a primary method of dissection and hemostasis from 1999. We were unable to perform prompt and thorough hemostasis in 2 patients from the US group (successful procedure rate 97.5%) because of ineffective post-ultrasonic coagulation of venous paravaginal varices (RALVH procedure) and of vena ovarica varices (LAVH, BSO procedure). The UltraCision was effective in all cases of lymphadenectomy. Successful procedure rate of the ELC operative technique was 100%. There were no statistically significant differences between the groups with regard to operation time, blood loss, hospital stay, and complications. There was a significant difference (P<0.001) in the number of lymph nodes harvested: a mean of 18.1 in the US group and 13.7 in the ELC group. We think that the difference was influenced by an increase in experience with laparoscopic lymph node dissection. The UltraCision operative technique ensures efficient dissection, coagulation, cutting, and grasping for LASS in women with cervical and endometrial cancer.
机译:这项回顾性研究评估和比较了两组患者的围手术期参数,这些患者通过不同的腹腔镜手术分期(LASS)手术技术治疗子宫癌。在1996年4月至2005年5月之间,连续选择了119例患有宫颈癌(n = 30)或临床I期子宫内膜癌(n = 89)的妇女,进行了腹腔镜辅助阴道子宫切除术(LAVH),全腹腔镜子宫切除术(TLH)或根治性腹腔镜辅助阴道切除术子宫切除术(RALVH)加上双侧输卵管卵巢切除术(BSO)和/或淋巴结清扫术(LND),采用电外科手术(ELC,n = 37)或超声(US,n = 82)手术技术(谐波剪切) ,UltraCision)。从1999年开始,UltraCision被用作主要的解剖和止血方法。由于超声后阴道副静脉曲张静脉曲张凝结无效,我们未能对2名美国组患者进行迅速彻底的止血(成功率为97.5%)。 RALVH程序)和卵巢静脉曲张(LAVH,BSO程序)。 UltraCision在所有淋巴结清扫术病例中均有效。 ELC手术技术的成功手术率为100%。两组之间在手术时间,失血量,住院时间和并发症方面无统计学差异。收集的淋巴结数目有显着差异(P <0.001):美国组平均为18.1,ELC组平均为13.7。我们认为差异是受腹腔镜淋巴结清扫经验增加的影响。 UltraCision手术技术可确保宫颈癌和子宫内膜癌女性的LASS有效解剖,凝结,切割和抓取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号